189102-97-4

Basic information

• Product Name: 5,6-dichloro-3H-iMidazo[4,5-b]pyridine
• Synonyms: 5,6-dichloro-3H-iMidazo[4,5-b]pyridine
• CAS NO: 189102-97-4
• Molecular Formula: C6H3Cl2N3
• Molecular Weight: 188.01412
• Mol File: 189102-97-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 204.3±50.0 °C(Predicted)
• Appearance: /
• Density: 1.79±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 6.17±0.40(Predicted)
• CAS DataBase Reference: 5,6-dichloro-3H-iMidazo[4,5-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-dichloro-3H-iMidazo[4,5-b]pyridine(189102-97-4)
• EPA Substance Registry System: 5,6-dichloro-3H-iMidazo[4,5-b]pyridine(189102-97-4)

Safety Data

• Hazardous Substances Data: 189102-97-4(Hazardous Substances Data)

Usage

General Description

5,6-Dichloro-3H-imidazo[4,5-b]pyridine, also known as DCIP, is a chemical compound with the molecular formula C7H4Cl2N2. It is a heterocyclic organic compound that is commonly used as a reagent in chemical and biological research. 5,6-Dichloro-3H-imidazo[4,5-b]pyridine is known for its ability to act as a potent inhibitor of protein kinase C, which is a crucial enzyme involved in various cell signaling pathways. Additionally, DCIP has been studied for its potential antitumor and antiviral activities, making it a significant target for pharmaceutical research. Its unique structure and biological activities make it a valuable tool for studying cellular processes and for the development of new therapeutic agents.

Upstream product

• 64-18-6 formic acid 
• 97941-89-4 5,6-dichloropyridine-2,3-diamine 
• 27048-04-0 2-amino-6-chloro-3-nitropyridine 
• 203794-33-6 2-amino-5,6-dichloro-3-nitropyridine 
• 122-51-0 orthoformic acid triethyl ester 

Downstream Products

• 1364717-17-8 C₂₂H₂₉ClN₄O₂Si 

Relevant articles and documents

3-[3'-hydroxymethyl)-4'-hydroxybutyl]imidazo[4,5-b]pyridines - Novel antiviral agents

Derivatives of 3- and 1-(4'-hydroxy-3'-(hydroxymethyl)butyl)-imidazo[4,5-b]pyridine were prepared in several steps from 2-amino-5-chloropyridine. Selected compounds were evaluated against human cytomegalovirus (HCMV), herpes simplex viruses (HSV1/HSV2) and varicella tester virus (VZV). Details of their synthesis and biological activities are presented.

HETERO RING-FUSED IMIDAZOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT

Disclosed is a compound which is useful as an AMPK activator. A compound represented by the formula: its pharmaceutically acceptable salt, or a solvate thereof, wherein a group represented by the formula: is a group represented by the formula: R1 /s